BPC-157 Treats Sphincter Failure-Induced Esophagitis AND Pancreatitis in Rats and Humans
BPC-157 improved sphincter dysfunction-related esophagitis and pancreatitis in both rat models AND human acute pancreatitis patients with low sphincter pressures — translational evidence spanning animal to human.
Quick Facts
What This Study Found
BPC-157 improved sphincter dysfunction-related esophagitis and pancreatitis in both rat models AND human acute pancreatitis patients with low sphincter pressures — translational evidence spanning animal to human.
Key Numbers
How They Did This
research study.
Why This Research Matters
Relevant for peptide research.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
Trust & Context
- Key Stat:
- Key finding BPC-157 improved sphincter dysfunction-related esophagitis and pancreatitis in both rat models AND human acute pancreatitis patients with low sphincte
- Evidence Grade:
- emerging evidence.
- Study Age:
- Published in 2011.
- Original Title:
- BPC 157 therapy to detriment sphincters failure-esophagitis-pancreatitis in rat and acute pancreatitis patients low sphincters pressure.
- Published In:
- Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 62(5), 527-34 (2011)
- Authors:
- Petrovic, I, Dobric, I(2), Drmic, D(5), Sever, M, Klicek, R, Radic, B, Brcic, L, Kolenc, D, Zlatar, M, Kunjko, K, Jurcic, D, Martinac, M, Rasic, Z, Boban Blagaic, A, Romic, Z, Seiwerth, S, Sikiric, P
- Database ID:
- RPEP-01836
Evidence Hierarchy
Frequently Asked Questions
What was studied?
BPC-157 Treats Sphincter Failure-Induced Esophagitis AND Pancreatitis in Rats and Humans
What was found?
BPC-157 improved sphincter dysfunction-related esophagitis and pancreatitis in both rat models AND human acute pancreatitis patients with low sphincter pressures — translational evidence spanning animal to human.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01836APA
Petrovic, I; Dobric, I; Drmic, D; Sever, M; Klicek, R; Radic, B; Brcic, L; Kolenc, D; Zlatar, M; Kunjko, K; Jurcic, D; Martinac, M; Rasic, Z; Boban Blagaic, A; Romic, Z; Seiwerth, S; Sikiric, P. (2011). BPC 157 therapy to detriment sphincters failure-esophagitis-pancreatitis in rat and acute pancreatitis patients low sphincters pressure.. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 62(5), 527-34.
MLA
Petrovic, I, et al. "BPC 157 therapy to detriment sphincters failure-esophagitis-pancreatitis in rat and acute pancreatitis patients low sphincters pressure.." Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2011.
RethinkPeptides
RethinkPeptides Research Database. "BPC 157 therapy to detriment sphincters failure-esophagitis-..." RPEP-01836. Retrieved from https://rethinkpeptides.com/research/petrovic-2011-bpc-157-therapy-to
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.